Dye composition comprising a cationic O-alkyl-substituted meta-phenylenediamine derivative

US9364404B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9364404-B2
Application numberUS-201314422095-A
CountryUS
Kind codeB2
Filing dateAug 12, 2013
Priority dateAug 17, 2012
Publication dateJun 14, 2016
Grant dateJun 14, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a meta-phenylenediamine compound of formula (I) below, the addition salts thereof with an acid and the solvates thereof: in which: R represents a hydrogen or halogen atom; a C 1 -C 4 alkyl radical; a carboxyl radical or a (C 1 -C 4 ) alkoxycarbonyl radical, R 1 represents a linear C 1 -C 10 alkyl radical substituted with a cationic radical, said alkyl radical being optionally interrupted with one or more oxygen atoms and/or with one or more NR 6 groups, said cationic radical being optionally substituted with one or more radicals chosen from C 1 -C 4 alkoxy or C 1 -C 4 (hydroxy)alkyl; R 6 represents a hydrogen atom or a linear or branched C 1 -C 4 alkyl radical; An − represents an anion or a mixture of anions which are organic or inorganic and cosmetically acceptable.

First claim

Opening claim text (preview).

The invention claimed is: 1. A meta-phenylenediamine compound chosen from formula (I), the addition salts thereof and the solvates thereof: wherein: R is chosen from a hydrogen or halogen atom; a C 1 -C 4 alkyl radical; a carboxyl radical and a (C 1 -C 4 ) alkoxycarbonyl radical, R 1 is a linear C 1 -C 10 alkyl radical substituted with a cationic radical, said alkyl radical optionally interrupted with one or more oxygen atoms and/or with one or more NR 6 groups, said cationic radical optionally substituted with one or more radicals chosen from hydroxyl, C 1 -C 4 alkoxy or C 1 -C 4 (hydroxy)alkyl and the cationic radical is a linear or branched or heterocyclic radical comprising a quaternary ammonium —N + RaRbRc, wherein Ra, Rb and Rc, which may be identical or different, are chosen from a C 1 -C 6 alkyl radical which may be substituted with a hydroxyl, a C 1 -C 4 alkoxy, or a C 1 -C 4 (hydroxy)alkyl, Ra and Rb may together form a 5- to 8-membered heterocycle, in which case the Rc radical is a C 1 -C 6 alkyl radical which may be substituted with a hydroxyl radical, a C 1 -C 4 alkoxy radical or a C 1 -C 4 (hydroxy)alkyl radical, said linear cationic radical is chosen from: triethylammonium, dimethylethylammonium, diisopropylmethylammonium radicals, and mixtures thereof, quaternary ammonium —N + RaRbRc, wherein Ra, Rb and Rc, which may be identical or different, are chosen from a C 1 -C 6 alkyl radical which may be substituted with a hydroxyl, a C 1 -C 4 alcoxy or a C 1 -C 4 (hydroxy)alkyl; R 6 is a hydrogen atom or a linear or branched C 1 -C 4 alkyl radical; An − is an anion or a mixture of anions which are organic or inorganic and cosmetically acceptable, with the exception of the following compounds: 2. The compound according to claim 1 , wherein R is a hydrogen atom. 3. The compound according to claim 1 , wherein R 1 is a linear C 2 -C 8 alkyl radical, optionally substituted with a cationic quaternary ammonium radical chosen from triethylammonium, dimethylethylammonium and diisopropylmethylammonium radicals, or mixtures thereof. 4. The compound according to claim 1 , wherein R 1 is a linear C 4 -C 8 alkyl radical, optionally substituted with a cationic quaternary ammonium radical —N + RaRbRc, wherein Ra, Rb and Rc, which may be identical or different, are chosen from a C 1 -C 6 hydroxyalkyl radical substituted with a hydroxyl radical or a C 1 -C 4 (hydroxy)alkyl radical, or mixtures thereof. 5. The compound according to claim 1 , wherein R 1 is a saturated linear C 2 -C 8 alkyl radical substituted with a 5- to 8-membered cationic heterocyclic radical of which one of the members is a quaternary ammonium or a non-cationic heterocyclic radical substituted with a cationic radical —N + RaRbRc, wherein Ra, Rb and Rc, which may be identical or different, are chosen from a C 1 -C 6 alkyl radical optionally substituted with a hydroxyl, C 1 -C 4 alkoxy or C 1 -C 4 (hydroxy)alkyl radical; or mixtures thereof. 6. The compound according to claim 1 , wherein R 1 is a saturated linear C 2 -C 8 alkyl radical substituted with a 5- to 8-membered cationic heterocyclic radical of which one of the members is a quaternary ammonium. 7. The compound according to claim 1 , wherein R 1 is a saturated linear C 4 -C 8 alkyl radical substituted with a 5- to 8-membered cationic heterocyclic radical of which one of the members is a quaternary ammonium. 8. The compound according to claim 1 , wherein R 1 is a saturated linear C 2 -C 8 alkyl radical substituted with a 5- to 8-membered cationic heterocyclic radical of which one of the members is a quaternary ammonium chosen from imidazolium radicals, pyridinium radicals, piperidinium radicals, piperazinium radicals, pyrrolidinium radicals, morpholinium radicals, pyrimidinium radicals, thiazoliums, benzimidazoliums, benzothiazoliums, oxazoliums, benzotriazoliums, pyrazoliums, triazoliums and benzoxazoliums, the cationic heterocycle optionally substituted with one or more radicals, which may be identical or different, chosen from a hydroxyl radical or a C 1 -C 4 (hydroxy)alkyl radical. 9. The compound according to claim 1 , R 1 is a saturated linear C 2 -C 8 alkyl radical substituted with a cationic heterocyclic radical chosen from the morpholinium radicals of formula (A), the pyrimidinium radicals of formula (B), the piperazinium radicals of formula (C), the cationic pyrrolidine radicals of formula (D), or the cationic piperidine radicals of formula (E) below: wherein R7 and R8 are, independently of each other, a C 1 -C 4 alkyl or C 1 -C 4 hydroxyalkyl radical. 10. The compound according to claim 1 , chosen from the following compounds: 2-(2,4-diaminophenoxy)-N,N-bis(2-hydroxyethyl)-N-methylethanaminium, 2-(2,4-diaminophenoxy)-N,N-bis(2-hydroxyethyl)-N-ethylethanaminium, An − , 2-(2,4-diaminophenoxy)-N,N,N-tris(2-hydroxyethyl)ethanaminium, An − , 1-[2-(2,4-diaminophenoxy)ethyl]-N, N, N-trimethylpiperidin-3-aminium, An − , 1-[2-(2,4-diaminophenoxy)ethyl]-1-methylpiperidinium, An − , 1-[3-(2,4-diaminophenoxy)propyl]-1-methylpiperidinium, An − , 1-[2-(2,4-diaminophenoxy)ethyl]-1-methylpyrrolidinium, An − , 4-[2-(2,4-diaminophenoxy)ethyl]-4-methylmorpholin-4-ium, An − , 4-[3-(2,4-diaminophenoxy)propyl]-4-methylmorpholin-4-ium, An − , 1-[2-(2,4-diaminophenoxy)ethyl]-3-methyl-1H-imidazol-3-ium, An − , 4-[2-(2,4-diaminophenoxy)ethyl]-1,1-dimethylpiperazin-1-ium, An − , 4-[3-(2,4-diaminophenoxy)propyl]-1,1-dimethylpiperazin-1-ium, An − , 4-[2-(2,4-diaminophenoxy)ethyl]-1,1-dimethylpiperazin-1-ium, An − , 1-[2-(2,4-diaminophenoxy)ethyl]-3-(2-hydroxyethyl)-1H-imidazol-3-ium, An − , 4-[2-(2,4-diaminophenoxy)ethyl]-1-(2-hydroxyethyl)-1-methylpiperazin-1-ium, An − , 4-[2-(2,4-diaminophenoxy)ethyl]-1,1-bis(2-hydroxyethyl)piperazin-1-ium, An − , 4-[2-(2,4-diaminophenoxy)ethyl]-1-ethyl-1-(2-hydroxyethyl)piperazin-1-ium, An − , and the salts and/or solvates or isomers thereof, and mixtures thereof. 11. A composition for dyeing keratin fibers, comprising, in a medium that is suitable for dyeing keratin fibers, at least one meta-phenylenediamine compound of formula (I), the addition salts thereof and the solvates thereof: wherein: R is chosen from a hydrogen or halogen atom; a C 1 -C 4 alkyl radical; a carboxyl radical and a (C 1 -C 4 ) alkoxycarbonyl radical, R 1 is a linear C 1 -C 10 alkyl radical substituted with a cationic radical, said alkyl radical optionally interrupted with one or more oxygen atoms and/or with one or more NR 6 groups, said cationic radical optionally substituted with one or more radicals chosen from hydroxyl, C 1 -C 4 alkoxy or C 1 -C 4 (hydroxy)alkyl and the cationic radical is a linear or branched or heterocyclic radical comprising a quaternary ammonium, this quaternary ammonium being of the type —N + RaRbRc, wherein Ra, Rb and Rc, which may be identical or different, are chosen from a C 1 -C 6 alkyl radical which may be substituted with a hydroxyl, a C 1 -C 4 alkoxy or a C 1 -C 4 (hydroxy)alkyl. Ra and Rb may together form a 5- to 8-membered heterocycle, in which case the Rc radical is a C 1 -C 6 alkyl radical optionally substituted with a hydroxyl radical, a C 1 -C 4 alkoxy radical or a C 1 -C 4 (hydroxy)alkyl radical, said linear cationic radical is cho

Assignees

Inventors

Classifications

  • A61K8/4913Primary

    having five membered rings, e.g. pyrrolidone carboxylic acid · CPC title

  • Other synthetic dyes of known constitution · CPC title

  • Nitrogen atoms not forming part of a nitro radical · CPC title

  • Nitrogen atoms (nitro radicals C07D211/38) · CPC title

  • Preparations for temporary colouring the hair, e.g. direct dyes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9364404B2 cover?
The invention relates to a meta-phenylenediamine compound of formula (I) below, the addition salts thereof with an acid and the solvates thereof: in which: R represents a hydrogen or halogen atom; a C 1 -C 4 alkyl radical; a carboxyl radical or a (C 1 -C 4 ) alkoxycarbonyl radical, R 1 represents a linear C 1 -C 10 alkyl radical substituted with a cationic radical, said alkyl radical being o…
Who is the assignee on this patent?
Oreal
What technology area does this patent fall under?
Primary CPC classification A61K8/4913. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).